The Role of Interferons in Driving Susceptibility to Asthma Following Bronchiolitis: Controversies and Research Gaps
Open Access
- 3 December 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 12
Abstract
Bronchiolitis is the most common cause of hospitalization in infancy and is associated with a higher risk for the development of childhood asthma. However, not all children hospitalized with bronchiolitis will develop asthma. The mechanisms underlying asthma development following bronchiolitis hospitalization are complex. Immune responses to respiratory viruses may underlie both bronchiolitis severity and long-term sequela (such as asthma). Interferons (IFNs) are important components of innate immune responses to respiratory viruses and could influence both asthma development and asthma exacerbations. However, the nature of the relationship between interferon production and wheezing illnesses is controversial. For example, low peripheral blood IFN responses at birth have been linked with recurrent wheeze and asthma development. In contrast, there is evidence that severe illnesses (e.g., hospitalization for bronchiolitis) are associated with increased IFN responses during acute infection (bronchiolitis hospitalization) and a higher risk for subsequent asthma diagnosis. Furthermore, mechanistic studies suggest that bronchial epithelial cells from asthmatic children have impaired IFN responses to respiratory viruses, which may enable increased viral replication followed by exaggerated secondary IFN responses. This review aims to discuss controversies around the role of IFNs as drivers of susceptibility to asthma development following bronchiolitis hospitalization. Past evidence from both mechanistic and cohort studies are discussed. We will highlight knowledge gaps that can inform future research study design.Keywords
This publication has 52 references indexed in Scilit:
- Whole Blood Gene Expression Profiles to Assess Pathogenesis and Disease Severity in Infants with Respiratory Syncytial Virus InfectionPLOS Medicine, 2013
- IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthmaJournal of Allergy and Clinical Immunology, 2013
- Impaired innate interferon induction in severe therapy resistant atopic asthmatic childrenMucosal Immunology, 2013
- Interferon-λ1 and Viral Wheeze in Asthma: A Gothic Duality?American Journal of Respiratory and Critical Care Medicine, 2012
- Evidence for a Causal Relationship between Allergic Sensitization and Rhinovirus Wheezing in Early LifeAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammationNature Medicine, 2008
- Severe Respiratory Syncytial Virus Bronchiolitis in Infants Is Associated with Reduced Airway Interferon Gamma and Substance PPLOS ONE, 2007
- Retinoic Acid-Inducible Gene I Mediates Early Antiviral Response and Toll-Like Receptor 3 Expression in Respiratory Syncytial Virus-Infected Airway Epithelial CellsJournal of Virology, 2007
- Suppression of IFN‐gamma production in atopic group at the acute phase of RSV infectionPediatric Allergy and Immunology, 2006
- “Hit-and-Run” Effects of Paramyxoviruses as a Basis for Chronic Respiratory DiseaseThe Pediatric Infectious Disease Journal, 2004